Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA

Bioconjugate Chemistry

Volumn 22, Issue 8, 2011, Pages 1673-1681

  Alam, Md Rowshon ^b   Ming, Xin ^a   Fisher, Michael ^a   Lackey, Jeremy G ^b   Rajeev, Kallanthottathil G ^b   Manoharan, Muthiah ^b   Juliano, Rudy L ^a  

^a UNC Hamner Institute for Drug Safety Sciences   (United States)

^b ALNYLAM PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS;

ASPARTIC; CELLULAR UPTAKE; CHEMICALLY MODIFIED; INTEGRINS; M21 CELLS; SMALL INTERFERING RNA; SUBCELLULAR DISTRIBUTION; SYNTHESISED; TARGETED DELIVERY; TRIVALENTS;

RNA;

ARGINYLGLYCYLASPARTIC ACID; CYCLIC ARGINYLGLYCYLASPARTIC ACID SMALL INTERFERING RNA CONJUGATE; LUCIFERASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; CYTOSOL; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; DRUG UPTAKE; HUMAN; HUMAN CELL; MELANOMA; PROTEIN EXPRESSION; SOLID PHASE SYNTHESIS;

EID: 80051769247     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200235q     Document Type: Article

References (29)

1. Bennett, C. F. and Swayze, E. E. (2010) RNA targeting therapeutics: Molecular mechanisms of antisense oligonucleotides as a therapeutic platform Annu. Rev. Pharmacol. Toxicol. 50, 259-293
2. Prakash, T. P. and Bhat, B. (2007) 2′-Modified oligonucleotides for antisense therapeutics Curr. Top. Med. Chem. 7, 641-649
3. Walton, S. P., Wu, M., Gredell, J. A., and Chan, C. (2010) Designing highly active siRNAs for therapeutic applications FEBS J. 277, 4806-4813
4. Vaishnaw, A. K., Gollob, J., Gamba-Vitalo, C., Hutabarat, R., Sah, D., Meyers, R., de Fougerolles, T., and Maraganore, J. (2010) A status report on RNAi therapeutics Silence 1, 14
5. Juliano, R., Bauman, J., Kang, H., and Ming, X. (2009) Biological barriers to therapy with antisense and siRNA oligonucleotides Mol. Pharmaceutics 6, 686-695
6. Whitehead, K. A., Langer, R., and Anderson, D. G. (2009) Knocking down barriers: Advances in siRNA delivery Nat. Rev. Drug Discovery 8, 129-138
7. Lares, M. R., Rossi, J. J., and Ouellet, D. L. (2010) RNAi and small interfering RNAs in human disease therapeutic applications Trends Biotechnol. 28, 570-579
8. Czech, B. and Hannon, G. J. (2011) Small RNA sorting: Matchmaking for Argonautes Nat. Rev. Genet. 12, 19-31
9. Akhtar, S. and Benter, I. F. (2007) Nonviral delivery of synthetic siRNAs in vivo J. Clin. Invest. 117, 3623-3632 (Pubitemid 350224068)
10. Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., Frank-Kamenetsky, M., Yip, K. N., Alvarez, R., Sah, D. W., de Fougerolles, A., Fitzgerald, K., Koteliansky, V., Akinc, A., Langer, R., and Anderson, D. G. (2010) Lipid-like materials for low-dose, in vivo gene silencing Proc. Natl. Acad. Sci. U.S.A. 107, 1864-1869
11. Kabanov, A. V. and Vinogradov, S. V. (2009) Nanogels as pharmaceutical carriers: Finite networks of infinite capabilities Angew. Chem., Int. Ed. 48, 5418-5429
12. Tamura, A. and Nagasaki, Y. (2010) Smart siRNA delivery systems based on polymeric nanoassemblies and nanoparticles Nanomedicine (London, U.K.) 5, 1089-1102
13. Tseng, Y. C., Mozumdar, S., and Huang, L. (2009) Lipid-based systemic delivery of siRNA Adv. Drug Delivery Rev. 61, 721-731
14. Juliano, R., Alam, M. R., Dixit, V., and Kang, H. (2008) Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides Nucleic Acids Res. 36, 4158-4171 (Pubitemid 351984831)
15. Zhu, L. and Mahato, R. I. (2010) Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation Bioconjugate Chem. 21, 2119-2127
16. Cesarone, G., Edupuganti, O. P., Chen, C. P., and Wickstrom, E. (2007) Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged d -peptide analogue of insulin-like growth factor 1 Bioconjugate Chem. 18, 1831-1840 (Pubitemid 350219981)
17. Ming, X. (2011) Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis Expert Opin. Drug Delivery 8, 435-449
18. Alam, M. R., Dixit, V., Kang, H., Li, Z. B., Chen, X., Trejo, J., Fisher, M., and Juliano, R. L. (2008) Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis Nucleic Acids Res. 36, 2764-2776 (Pubitemid 351659588)
19. Alam, M. R., Ming, X., Dixit, V., Fisher, M., Chen, X., and Juliano, R. L. (2010) The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking Oligonucleotides 20, 103-109
20. Ming, X., Alam, M. R., Fisher, M., Yan, Y., Chen, X., and Juliano, R. L. (2010) Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor Nucleic Acids Res. 38, 6567-6576
21. Nakagawa, O., Ming, X., Huang, L., and Juliano, R. L. (2010) Targeted intracellular delivery of antisense oligonucleotides via conjugation with small-molecule ligands J. Am. Chem. Soc. 132, 8848-8849
22. Felding-Habermann, B., Mueller, B. M., Romerdahl, C. A., and Cheresh, D. A. (1992) Involvement of integrin alpha V gene expression in human melanoma tumorigenicity J. Clin. Invest. 89, 2018-2022
23. Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., Zimmermann, T., Koteliansky, V., Manoharan, M., and Stoffel, M. (2007) Mechanisms and optimization of in vivo delivery of lipophilic siRNAs Nat. Biotechnol. 25, 1149-1157 (Pubitemid 47538115)
24. 64Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor α(v)β(3) integrin expression J. Nucl. Med. 48, 1162-1171 (Pubitemid 47052657)
25. Khalil, I. A., Kogure, K., Akita, H., and Harashima, H. (2006) Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery Pharmacol. Rev. 58, 32-45
26. Caswell, P. T. and Norman, J. C. (2006) Integrin trafficking and the control of cell migration Traffic 7, 14-21
27. Desgrosellier, J. S. and Cheresh, D. A. (2010) Integrins in cancer: Biological implications and therapeutic opportunities Nat. Rev. Cancer 10, 9-22
28. Eliceiri, B. P. and Cheresh, D. A. (2000) Role of alpha v integrins during angiogenesis Cancer J. 6 (Suppl. 3) S245-S249
29. Sadowski, L., Pilecka, I., and Miaczynska, M. (2009) Signaling from endosomes: Location makes a difference Exp. Cell Res. 315, 1601-1609